Presentation: Drafting Patent Strategies for Genetically Modified vs. Unmodified Cell Therapies
Time: 9:15 am
day: Day Two
Details:
- Compare how patent strategies differ for genetically modified versus unmodified allogeneic cell therapies under U.S. law
- Explore key challenges in claiming unmodified cells, including novelty, inventiveness, and eligibility
- Learn practical drafting approaches to protect compositions, methods, and therapeutic use across both therapy types
